WASHINGTON, DC—June 4, 2025—Media and the public are invited to listen to the FDA’s Center for Biologics Evaluation and Research (CBER) Cell and Gene Therapy (CGT) Roundtable.
This event will gather world-renowned experts from industry and academia, and stakeholders from patient organizations to discuss approaches supporting CGT research and development.